Broadway Research Bldg., Rm 880, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA.
J Virol. 2010 Jul;84(14):7018-28. doi: 10.1128/JVI.00548-10. Epub 2010 May 5.
A subset of HIV-1-infected patients known as elite controllers or suppressors (ES) control the virus naturally. We have previously demonstrated sequence discordance between proviral and plasma gag clones in ES, much of which can be attributed to selective pressure from the host (J. R. Bailey, T. M. Williams, R. F. Siliciano, and J. N. Blankson, J. Exp. Med. 203:1357-1369, 2006). However, it is not clear whether ongoing viral replication continues in ES once the control of viremia has been established or whether selective pressure impacts this evolution. The cytotoxic T-lymphocyte (CTL) response in ES often targets Gag and frequently is superior to that of HIV-1 progressors, partially due to the HLA class I alleles B57/5801 and B27, which are overrepresented in ES. We therefore examined longitudinal plasma and proviral gag sequences from HLA-B57/5801 and -B27 ES. Despite the highly conserved nature of gag, we observed clear evidence of evolution in the plasma virus, largely due to synonymous substitutions. In contrast, evolution was rare in proviral clones, suggesting that ongoing replication in ES does not permit the significant reseeding of the latent reservoir. Interestingly, there was little continual evolution in CTL epitopes, and we detected de novo CTL responses to autologous viral mutants. Thus, some ES control viremia despite ongoing replication and evolution.
一部分 HIV-1 感染者被称为精英控制者或抑制者(ES),他们能够自然地控制病毒。我们之前已经证明 ES 中前病毒和血浆 gag 克隆之间存在序列不一致,其中大部分可以归因于宿主的选择压力(J. R. Bailey、T. M. Williams、R. F. Siliciano 和 J. N. Blankson,J. Exp. Med. 203:1357-1369, 2006)。然而,目前尚不清楚在控制病毒血症后,ES 中是否仍在进行病毒复制,或者选择压力是否会影响这种进化。ES 中的细胞毒性 T 淋巴细胞(CTL)反应通常针对 gag,并且通常优于 HIV-1 进展者的 CTL 反应,部分原因是 HLA Ⅰ类等位基因 B57/5801 和 B27 在 ES 中过度表达。因此,我们检测了 HLA-B57/5801 和 -B27 ES 的纵向血浆和前病毒 gag 序列。尽管 gag 具有高度保守性,但我们观察到在血浆病毒中存在明显的进化证据,主要是由于同义替换。相比之下,前病毒克隆中很少发生进化,这表明 ES 中的持续复制不会允许潜伏库的大量重新播种。有趣的是,CTL 表位的连续进化很少,我们检测到针对自身病毒突变体的新的 CTL 反应。因此,尽管存在持续的复制和进化,一些 ES 仍能控制病毒血症。